Patents by Inventor Eun Kyoung Seo

Eun Kyoung Seo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11389411
    Abstract: The present disclosure relates to a pharmaceutical composition for suppressing cancer metastasis containing, as an active ingredient, an activator compound of the cancer metastasis inhibitor Nm23, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound according to the present disclosure may suppress the metastasis of cancer cells by promoting the activity of Nm23 associated with cancer metastasis, and thus may be useful as a pharmaceutical composition for suppressing cancer metastasis.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: July 19, 2022
    Assignee: EWHA UNIVERSITY—INDUSTRY COLLABORATION FOUNDATION
    Inventors: Kong Joo Lee, Hee-Yoon Lee, Je Jin Lee, Eun-Kyoung Seo, Eun Sun Lee, Hwang Suk Kim, Hongsoo Lee
  • Publication number: 20200078319
    Abstract: The present disclosure relates to a pharmaceutical composition for suppressing cancer metastasis containing, as an active ingredient, an activator compound of the cancer metastasis inhibitor Nm23, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound according to the present disclosure may suppress the metastasis of cancer cells by promoting the activity of Nm23 associated with cancer metastasis, and thus may be useful as a pharmaceutical composition for suppressing cancer metastasis.
    Type: Application
    Filed: April 30, 2018
    Publication date: March 12, 2020
    Applicant: EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
    Inventors: Kong Joo LEE, Hee-Yoon LEE, Je Jin LEE, Eun-Kyoung SEO, Eun Sun LEE, Hwang Suk KIM, Hongsoo LEE
  • Patent number: 8431166
    Abstract: The present invention relates to a composition comprising an extract of Anemarrhena asphodeloides Bunge or the compounds isolated from the same, as an active ingredient. In particular, the extract and compounds have the excellent inhibitory effects on adipocyte differentiation, and thus can be used in a pharmaceutical composition and functional food for the prevention and treatment of lipid metabolism disorders.
    Type: Grant
    Filed: December 8, 2009
    Date of Patent: April 30, 2013
    Assignee: EWHA University-Industry Collaboration Foundation
    Inventors: Eun Kyoung Seo, Eun Sook Hwang, Ui Joung Youn, Joo Won Nam
  • Publication number: 20120070515
    Abstract: The present invention relates to a composition comprising an extract of Anemarrhena asphodeloides Bunge or the compounds isolated from the same, as an active ingredient. In particular, the extract and compounds have the excellent inhibitory effects on adipocyte differentiation, and thus can be used in a pharmaceutical composition and functional food for the prevention and treatment of lipid metabolism disorders.
    Type: Application
    Filed: December 8, 2009
    Publication date: March 22, 2012
    Applicant: EWHA UNIVERSITY- INDUSTRY COLLABORATION FOUNDATION
    Inventors: Eun Kyoung Seo, Eun Sook Hwang, Ui Joung Youn, Joo Won Nam